Kiniksa Pharmaceuticals International, plc APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition
Kiniksa Pharmaceuticals International, plc (KNSA) reported APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition of $6.07 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2026-03-31 was $6.07M, a 119.40% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2025-09-30 was $11.90M, a 77.89% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2025-03-31 was $2.77M, a 23.39% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for the quarter ending 2024-09-30 was $6.69M, a 1111.78% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2023 was $1.50M, a 40.65% decline from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2022 was $2.52M, a 57.20% decline from fiscal 2021.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2021 was $5.88M, a 10.18% decline from fiscal 2020.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, espp, increase for cost recognition for fiscal 2020 was $6.55M, a 485.52% increase from fiscal 2019.
| Period end | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-03-31 | $6.07M 10-Q · filed 2026-04-28 | |||
| 2025-09-30 | $11.90M 10-Q · filed 2025-10-28 | |||
| 2025-03-31 | $2.77M 10-Q · filed 2026-04-28 | |||
| 2024-09-30 | $6.69M 10-Q · filed 2025-10-28 | $6.51M derived: sum of 2 quarters · filed 2025-10-28 | $10.12M derived: sum of 3 quarters · filed 2025-10-28 | |
| 2024-06-30 | -$178.00K 10-Q · filed 2025-10-28 | $3.44M derived: sum of 2 quarters · filed 2025-10-28 | ||
| 2024-03-31 | $3.61M 10-Q · filed 2025-10-28 | |||
| 2023-12-31 | $1.50M 10-K · filed 2024-02-28 | |||
| 2023-09-30 | $552.00K 10-Q · filed 2024-10-29 | $710.00K derived: sum of 2 quarters · filed 2024-10-29 | $800.00K derived: sum of 3 quarters · filed 2024-10-29 | |
| 2023-06-30 | $158.00K 10-Q · filed 2024-10-29 | $248.00K derived: sum of 2 quarters · filed 2024-10-29 | ||
| 2023-03-31 | $90.00K 10-Q · filed 2024-10-29 | |||
| 2022-12-31 | $2.52M 10-K · filed 2024-02-28 | |||
| 2022-09-30 | $360.00K 10-Q · filed 2023-11-02 | $902.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.32M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $542.00K 10-Q · filed 2023-11-02 | $965.00K derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $423.00K 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $5.88M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $2.68M 10-Q · filed 2022-11-03 | $3.57M derived: sum of 2 quarters · filed 2022-11-03 | $4.67M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $887.00K 10-Q · filed 2022-11-03 | $1.99M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $1.11M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $6.55M 10-K · filed 2023-03-02 | |||
| 2020-03-31 | $2.41M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $1.12M 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $377.00K 10-K · filed 2021-02-25 |